Italy's Farmindustria backs govt over late payments

16 March 2009

The Italian research-based pharmaceutical association, Farmindustria, has issued a statement supporting the government's move to speed up  public sector payments of invoices. The Campania region in particular  has an average settlement time of 407 days, while the national average  is 231 days.

Sergio Dompe, president of the drugmakers' group, said: "it is important  to clarify an issue that is so sensitive to all the supplier companies  of goods and services to the SSN [state health care system]." He noted  that public administrations in Italy are far slower to pay invoices than  most of their European counterparts, which Mr Dompe added puts a strain  on drugmakers who depend for much of their income on prices that are  negotiated with the Italian Drug Agency (AIFA).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight